Six Chinese Biotechs Bag $403m In Fresh Financing Rounds

fund raising
Chinese biotechs raise new funds for immuno-oncology therapies, neurodegenerative drugs, and vaccines. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from China

More from Focus On Asia